Arena Pharmaceuticals, Inc.

    Jurisdiction
    United States
    ISIN
    US0400476075 (ARNA)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    1 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €46.33K
    Gross margin
    100.0%
    EBIT
    -€536.66M
    EBIT margin
    -1,158,285.2%
    Net income
    -€529.76M
    Net margin
    -1,143,403.7%

    Statement period: - (published )

    Dividends

    No dividend payouts

    Products

    Product Revenue
    Collaboration And Other Revenue €54.00K 116.6%
    License €0.00 0.0%
    Royalty €0.00 0.0%

    Earnings Calls

    Latest earnings call: November 4, 2021

    Add to watchlist

    Notifications